UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 21, 2010
MASIMO CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 001-33642 | 33-0368882 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
40 Parker Irvine, California |
92618 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (949) 297-7000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. | Other Events. |
On December 21, 2010, Masimo Corporation determined to initiate a voluntary recall of its Pronto-7 rainbow sensors, which are currently in limited market release. Together with Pronto-7 Spot Check Pulse CO-Oximeters, the sensors allow users to noninvasively measure hemoglobin (SpHb) simply and quickly, thereby improving clinical decision making in physician offices and emergency departments.
The Company has recently become aware that, due to the seasonal colder temperatures, the sensor may incorrectly measure the patients actual finger temperature when performing a SpHb measurement. As a result, the Pronto-7 Spot Check Pulse CO-Oximeter may provide an incorrect SpHb measurement. Having identified this issue, Masimo is working quickly and diligently to develop a replacement Pronto-7 rainbow sensor that will address the differences between actual finger temperature and the measured temperature. The Company plans to have the revised Pronto-7 sensors available in the first quarter of 2011.
Masimo estimates that the total costs resulting from this voluntary recall will be approximately $500,000 to $700,000, although this is an estimate and the actual cost may differ. No other Masimo products, including the actual Pronto-7 handheld device, are affected by this voluntary recall.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, Masimo Corporation has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MASIMO CORPORATION | ||||||
Date: December 21, 2010 | By: | /s/ Mark P. de Raad | ||||
Mark P. de Raad Executive Vice President, Chief Financial Officer & Secretary
(Principal Financial and Accounting Officer) |